ZA968525B - Process for the preparation of enantiomerically pure imidazolyl compounds - Google Patents

Process for the preparation of enantiomerically pure imidazolyl compounds

Info

Publication number: ZA968525B
Authority: ZA; South Africa
Prior art keywords: addition salt; acid; mixture; enantiomer; compound
Prior art date: 1995-10-13

Application number

ZA968525A

Other languages

English (en)

Inventor

Paulus Franciscus Corneli Meij

Jan-Maarten Verbeek

Original Assignee

Duphar Int Res

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-10-13

Filing date

1996-10-09

Publication date

1997-05-20

1996-10-09 Application filed by Duphar Int Res filed Critical Duphar Int Res

1997-05-20 Publication of ZA968525B publication Critical patent/ZA968525B/xx

Links

238000000034 method Methods 0.000 title abstract 3
125000002883 imidazolyl group Chemical group 0.000 title 1
150000003839 salts Chemical class 0.000 abstract 7
239000002253 acid Substances 0.000 abstract 6
239000000203 mixture Substances 0.000 abstract 6
150000001732 carboxylic acid derivatives Chemical class 0.000 abstract 4
150000001875 compounds Chemical class 0.000 abstract 3
239000012452 mother liquor Substances 0.000 abstract 3
HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 2
ODHCTXKNWHHXJC-GSVOUGTGSA-N Pyroglutamic acid Natural products OC(=O)[C@H]1CCC(=O)N1 ODHCTXKNWHHXJC-GSVOUGTGSA-N 0.000 abstract 2
-1 imidazolyl compound Chemical class 0.000 abstract 2
238000000926 separation method Methods 0.000 abstract 2
ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 abstract 1
ODHCTXKNWHHXJC-UHFFFAOYSA-N acide pyroglutamique Natural products OC(=O)C1CCC(=O)N1 ODHCTXKNWHHXJC-UHFFFAOYSA-N 0.000 abstract 1
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
229910052739 hydrogen Inorganic materials 0.000 abstract 1
239000001257 hydrogen Substances 0.000 abstract 1
125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/06—Peri-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Epoxy Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

ZA968525A 1995-10-13 1996-10-09 Process for the preparation of enantiomerically pure imidazolyl compounds ZA968525B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP95202765		1995-10-13

Publications (1)

Publication Number	Publication Date
ZA968525B true ZA968525B (en)	1997-05-20

Family

ID=8220714

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA968525A ZA968525B (en)	1995-10-13	1996-10-09	Process for the preparation of enantiomerically pure imidazolyl compounds

Country Status (24)

Country	Link
US (1)	US5663343A (fr)
EP (1)	EP0768309B1 (fr)
JP (2)	JP4590038B2 (fr)
KR (1)	KR100459745B1 (fr)
CN (1)	CN1060774C (fr)
AT (1)	ATE224896T1 (fr)
AU (1)	AU702594B2 (fr)
CA (1)	CA2187484C (fr)
CZ (1)	CZ288042B6 (fr)
DE (1)	DE69623900T2 (fr)
DK (1)	DK0768309T3 (fr)
DZ (1)	DZ2104A1 (fr)
ES (1)	ES2183908T3 (fr)
HK (1)	HK1000446A1 (fr)
HU (1)	HU226620B1 (fr)
IL (1)	IL119400A (fr)
NO (1)	NO307257B1 (fr)
NZ (1)	NZ299562A (fr)
PT (1)	PT768309E (fr)
RU (1)	RU2162085C2 (fr)
SK (1)	SK283471B6 (fr)
TW (1)	TW513423B (fr)
UA (1)	UA48947C2 (fr)
ZA (1)	ZA968525B (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19813661A1 (de) *	1997-08-01	1999-02-04	Solvay Pharm Gmbh	Gegen Racemisierung stabilisierte pharmazeutische Zubereitungen von Cilansetron
US6372919B1 (en) *	2001-01-11	2002-04-16	Dov Pharmaceutical, Inc.	(+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as an anti-depressant agent
RU2213562C2 (ru) *	2001-03-14	2003-10-10	Научно-исследовательский институт фармакологии РАМН	Лекарственная композиция
GB0216027D0 (en) *	2002-07-10	2002-08-21	Arachnova Therapeutics Ltd	New therapeutic use
US20040048874A1 (en) *	2001-05-22	2004-03-11	Bardsley Hazel Judith	New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D]pyrimidine
US7015333B2 (en) *	2002-11-18	2006-03-21	Solvay Pharmaceuticals B.V.	Process for preparation of imidazolyl compounds
EP1424337A1 (fr) *	2002-11-26	2004-06-02	Solvay Pharmaceuticals GmbH	Dérivés 4-hydroxy de 5,6,9,10-tetrahydro-10-((2-méthyl-1h-imidazol-1-yl)méthyl)-4h-pyrido-(3,2,1-jk)-carbazol-11(8h)-one
MXPA05007381A (es) *	2003-01-13	2006-02-10	Dynogen Pharmaceuticals Inc	Metodo para el tratamiento de transtornos funcionales del intestino.
NZ541009A (en) *	2003-01-13	2007-09-28	Dynogen Pharmaceuticals Inc	Method of treating nausea, vomiting, retching or any combination thereof
EP1539181B1 (fr) *	2003-04-04	2007-06-27	Dynogen Pharmaceuticals Inc.	Methode de traitement de troubles des voies urinaires inferieures
EP1706394B1 (fr) *	2003-11-12	2014-12-17	Dr. Reddy's Laboratories, Inc.	Préparation d'escitaloprame
US20070043100A1 (en)	2005-08-16	2007-02-22	Hagen Eric J	Novel polymorphs of azabicyclohexane
US20080045725A1 (en)	2006-04-28	2008-02-21	Murry Jerry A	Process For The Synthesis of (+) And (-)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane
US7601856B2 (en)	2006-07-27	2009-10-13	Wyeth	Benzofurans as potassium ion channel modulators
US7662831B2 (en)	2006-07-27	2010-02-16	Wyeth Llc	Tetracyclic indoles as potassium channel modulators
JP5156222B2 (ja) *	2006-11-28	2013-03-06	エムキュアファーマシューティカルズリミテッド	制吐作用化合物の新たな製造方法
GB0910373D0 (en) *	2009-06-16	2009-07-29	Filtrona Int Ltd	Tabacco smoke filter
US9806720B1 (en) *	2016-10-07	2017-10-31	Analog Devices Global	Compound semiconductor based inverter
CA3100706A1 (fr) *	2018-05-18	2019-11-21	Kura Oncology, Inc.	Synthese de tipifarnib

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL7413843A (nl) *	1974-10-23	1976-04-27	Stamicarbon	Optische scheiding van fenylglycine-amide.
US4463176A (en) *	1982-09-13	1984-07-31	Mead Johnson & Company	Process for resolution of optical isomers
US4849527A (en) *	1982-09-13	1989-07-18	Bristol-Myers Company	Process for resolution of optical isomers
LU88268I2 (fr) *	1984-01-25	1994-02-03
DE3885357T2 (de) *	1987-06-29	1994-03-24	Duphar Int Res	Anellierte Indolderivate.
GB8812636D0 (en) *	1988-05-27	1988-06-29	Glaxo Group Ltd	Chemical compounds
EP0350129A1 (fr) *	1988-07-07	1990-01-10	Duphar International Research B.V	Indole cétones annelées avec un substituant imidazolylalkyle
DE4238553A1 (de) *	1992-11-14	1994-05-19	Kali Chemie Pharma Gmbh	Neue Imidazol-1-yl-Verbindungen enthaltende Arzneimittel
RU2041876C1 (ru) *	1993-12-29	1995-08-20	Научно-производственный центр "Фармзащита"	Способ получения 1,2,3,9- тетрагидро-9-метил-3- [(2-метил-1н- имидазол-1-ил) метил]-4н- карбазол-4-она или его солей, или их гидратов, и промежуточные продукты для их синтеза

1996
- 1996-09-26 AU AU65856/96A patent/AU702594B2/en not_active Ceased
- 1996-10-03 TW TW085112098A patent/TW513423B/zh not_active IP Right Cessation
- 1996-10-08 CZ CZ19962947A patent/CZ288042B6/cs not_active IP Right Cessation
- 1996-10-08 SK SK1287-96A patent/SK283471B6/sk not_active IP Right Cessation
- 1996-10-08 JP JP28461296A patent/JP4590038B2/ja not_active Expired - Fee Related
- 1996-10-09 HU HU9602778A patent/HU226620B1/hu not_active IP Right Cessation
- 1996-10-09 RU RU96120366/04A patent/RU2162085C2/ru not_active IP Right Cessation
- 1996-10-09 CA CA002187484A patent/CA2187484C/fr not_active Expired - Fee Related
- 1996-10-09 NO NO964282A patent/NO307257B1/no not_active IP Right Cessation
- 1996-10-09 ZA ZA968525A patent/ZA968525B/xx unknown
- 1996-10-09 DZ DZ960148A patent/DZ2104A1/fr active
- 1996-10-10 ES ES96202829T patent/ES2183908T3/es not_active Expired - Lifetime
- 1996-10-10 UA UA96103876A patent/UA48947C2/uk unknown
- 1996-10-10 DE DE69623900T patent/DE69623900T2/de not_active Expired - Lifetime
- 1996-10-10 CN CN96122637A patent/CN1060774C/zh not_active Expired - Fee Related
- 1996-10-10 EP EP96202829A patent/EP0768309B1/fr not_active Expired - Lifetime
- 1996-10-10 DK DK96202829T patent/DK0768309T3/da active
- 1996-10-10 US US08/728,794 patent/US5663343A/en not_active Expired - Lifetime
- 1996-10-10 PT PT96202829T patent/PT768309E/pt unknown
- 1996-10-10 IL IL11940096A patent/IL119400A/xx not_active IP Right Cessation
- 1996-10-10 KR KR1019960044972A patent/KR100459745B1/ko not_active Expired - Fee Related
- 1996-10-10 AT AT96202829T patent/ATE224896T1/de active
- 1996-10-11 NZ NZ299562A patent/NZ299562A/en not_active IP Right Cessation
1997
- 1997-07-19 HK HK97101586A patent/HK1000446A1/en not_active IP Right Cessation
2010
- 2010-04-15 JP JP2010094211A patent/JP2010159292A/ja active Pending

Also Published As

Publication number	Publication date
CA2187484A1 (fr)	1997-04-14
HUP9602778A3 (en)	1997-08-28
HU9602778D0 (en)	1996-11-28
CN1160053A (zh)	1997-09-24
SK283471B6 (sk)	2003-08-05
CA2187484C (fr)	2006-09-05
KR970021080A (ko)	1997-05-28
IL119400A (en)	2000-02-29
AU702594B2 (en)	1999-02-25
RU2162085C2 (ru)	2001-01-20
EP0768309A1 (fr)	1997-04-16
ES2183908T3 (es)	2003-04-01
SK128796A3 (en)	1997-05-07
DE69623900D1 (de)	2002-10-31
NO964282L (no)	1997-04-14
AU6585696A (en)	1997-04-17
TW513423B (en)	2002-12-11
JPH09183779A (ja)	1997-07-15
NZ299562A (en)	1997-09-22
CZ288042B6 (cs)	2001-04-11
DK0768309T3 (da)	2002-12-09
EP0768309B1 (fr)	2002-09-25
UA48947C2 (uk)	2002-09-16
US5663343A (en)	1997-09-02
PT768309E (pt)	2003-02-28
NO964282D0 (no)	1996-10-09
JP2010159292A (ja)	2010-07-22
HUP9602778A2 (en)	1997-05-28
IL119400A0 (en)	1997-01-10
CN1060774C (zh)	2001-01-17
NO307257B1 (no)	2000-03-06
HU226620B1 (en)	2009-04-28
CZ294796A3 (en)	1997-05-14
HK1000446A1 (en)	2003-01-10
DE69623900T2 (de)	2003-07-31
KR100459745B1 (ko)	2005-01-26
ATE224896T1 (de)	2002-10-15
JP4590038B2 (ja)	2010-12-01
DZ2104A1 (fr)	2002-07-22

Publication	Publication Date	Title
ZA968525B (en)	1997-05-20	Process for the preparation of enantiomerically pure imidazolyl compounds
US5281722A (en)	1994-01-25	Preparation and use of salts of the pure enantiomers of alpha-lipoic acid
FI110776B (fi)	2003-03-31	Menetelmä substituoitujen fenyylipropionihappojen oleellisesti puhtaiden enantiomeerien valmistamiseksi
RU96120366A (ru)	1998-12-27	Способ получения энантиомерно чистых соединений имидазолила, энантиомерно чистая кислая аддитивная соль имидазолила и в-пироглутаминовой кислоты
EP0623104B1 (fr)	1997-08-27	Resolution du profene
HUT54156A (en)	1991-01-28	Process for producing new n-heteroarylpurine-6-amine derivatives and pharmaceutical compositions comprising such compounds
US6054594A (en)	2000-04-25	Process for the production of enantiomerically enriched N-acylazetidine-2-carboxylic acids
SK140898A3 (en)	1999-05-07	Improved process for the production of enantiomerically-pure azetidine-2-carboxylic acid
CA2623355A1 (fr)	2007-04-05	Resolution de derives d'acide alpha-(phenoxy) phenylacetique avec des naphtyl-alkylamines
PL343556A1 (en)	2001-08-27	Method for producing enantiomer-free n-methyl-n- [(1s)-1-phenyl- 2-((3s)- 3-hydroxypyrrolidine- 1-yl)ethyl]- 2,2-diphenyl acetamide
EP0220435A1 (fr)	1987-05-06	Procédé de préparation de semi-esters optiquement actifs
JPS6323824A (ja)	1988-02-01	酸性α−水素を有するアミンの光学分割およびラセミ化方法
Schjelderup et al.	1986	The absolute configuration of oxyphencyclimine, a parasympatholytic drug. Syntheses of both enantiomers
JPH10506384A (ja)	1998-06-23	二環式ラクタム鏡像体の分離法
US4584313A (en)	1986-04-22	(Substituted-phenyl)-5-oxo-2-pyrrolidinepropanoic acids and esters thereof, and use for reversing electroconvulsive shock-induced amnesia
HU205594B (en)	1992-05-28	Process for producing optical isomeres of cyclopropane-carboxylic acids5
US6166224A (en)	2000-12-26	Method for racemization of optically active azetidine-2-carboxylate
CA2089626A1 (fr)	1993-08-18	Methode de preparation de (r) et de (s)-1,2-isopropylideneglycerol
WO1990002118A1 (fr)	1990-03-08	Derives et precurseurs de captopril et ses analogues
HU202803B (en)	1991-04-29	Process for separation of optical isomers of m-phenoxymandelic acid